Delivery, Engineering And Optimization Of Systems, Methods And Compositions For Targeting And Modeling Diseases And Disorders Of Post Mitotic Cells - EP3011032

The patent EP3011032 was granted to Massachusetts Institute OF Technology on Oct 16, 2019. The application was originally filed on Jun 11, 2014 under application number EP14735795A. The patent is currently recorded with a legal status of "Revoked".

EP3011032

MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Application Number
EP14735795A
Filing Date
Jun 11, 2014
Status
Revoked
Dec 3, 2021
Grant Date
Oct 16, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MATHYS & SQUIREJul 16, 2020WILDINGADMISSIBLE
PATENT BOUTIQUEMar 2, 2020-ADMISSIBLE

Patent Citations (132) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS20040491026-
DESCRIPTIONUS20070953797-
DESCRIPTIONUS20080064798-
DESCRIPTIONUS20090511940-
DESCRIPTIONWO1994US05700-
DESCRIPTIONWO2007US84654-
DESCRIPTIONEP0264166
DESCRIPTIONEP1519714
DESCRIPTIONEP1664316
DESCRIPTIONEP1766035
DESCRIPTIONEP1781593
DESCRIPTIONUS11029
DESCRIPTIONUS2003087817
DESCRIPTIONUS2004013648
DESCRIPTIONUS2004171156
DESCRIPTIONUS2005019923
DESCRIPTIONUS2005287127
DESCRIPTIONUS2006030837
DESCRIPTIONUS2006281180
DESCRIPTIONUS2007025970
DESCRIPTIONUS2007054961
DESCRIPTIONUS2007093878
DESCRIPTIONUS2008267903
DESCRIPTIONUS2009007284
DESCRIPTIONUS2009017543
DESCRIPTIONUS2009111106
DESCRIPTIONUS2009222937
DESCRIPTIONUS2009271881
DESCRIPTIONUS2010146651
DESCRIPTIONUS2010229252
DESCRIPTIONUS2010291048
DESCRIPTIONUS2010311124
DESCRIPTIONUS2010317109
DESCRIPTIONUS2011016540
DESCRIPTIONUS2011023139
DESCRIPTIONUS2011023144
DESCRIPTIONUS2011023145
DESCRIPTIONUS2011023146
DESCRIPTIONUS2011023153
DESCRIPTIONUS2011059502
DESCRIPTIONUS2011091441
DESCRIPTIONUS2011117189
DESCRIPTIONUS2011142917
DESCRIPTIONUS2011158957
DESCRIPTIONUS2011182867
DESCRIPTIONUS2011195123
DESCRIPTIONUS2011225664
DESCRIPTIONUS2011230839
DESCRIPTIONUS2011265198
DESCRIPTIONUS2011293571
DESCRIPTIONUS2011293703
DESCRIPTIONUS2012017290
DESCRIPTIONUS2012159653
DESCRIPTIONUS2012164118
DESCRIPTIONUS2012204282
DESCRIPTIONUS2012251560
DESCRIPTIONUS2012251618
DESCRIPTIONUS2012295960
DESCRIPTIONUS2012328580
DESCRIPTIONUS2013122591
DESCRIPTIONUS2013137104
DESCRIPTIONUS2013145487
DESCRIPTIONUS2013171732
DESCRIPTIONUS2013183282
DESCRIPTIONUS2013202678
DESCRIPTIONUS2013236946
DESCRIPTIONUS2013244279
DESCRIPTIONUS2013245107
DESCRIPTIONUS2013252281
DESCRIPTIONUS2013253040
DESCRIPTIONUS2013302401
DESCRIPTIONUS4186183
DESCRIPTIONUS4217344
DESCRIPTIONUS4235871
DESCRIPTIONUS4261975
DESCRIPTIONUS4485054
DESCRIPTIONUS4501728
DESCRIPTIONUS4774085
DESCRIPTIONUS4797368
DESCRIPTIONUS4837028
DESCRIPTIONUS4873316
DESCRIPTIONUS4897355
DESCRIPTIONUS4946787
DESCRIPTIONUS5049386
DESCRIPTIONUS5173414
DESCRIPTIONUS5210015
DESCRIPTIONUS5445934
DESCRIPTIONUS5543158
DESCRIPTIONUS5580859
DESCRIPTIONUS5589466
DESCRIPTIONUS5593972
DESCRIPTIONUS5846946
DESCRIPTIONUS5855913
DESCRIPTIONUS5985309
DESCRIPTIONUS6007845
DESCRIPTIONUS6750059
DESCRIPTIONUS7206639
DESCRIPTIONUS7259015
DESCRIPTIONUS7303910
DESCRIPTIONUS7351585
DESCRIPTIONUS7745651
DESCRIPTIONUS7776321
DESCRIPTIONUS7799565
DESCRIPTIONUS7803397
DESCRIPTIONUS7838658
DESCRIPTIONUS7901708
DESCRIPTIONUS7915399
DESCRIPTIONUS7982027
DESCRIPTIONUS8058069
DESCRIPTIONUS8101741
DESCRIPTIONUS8188263
DESCRIPTIONUS8236943
DESCRIPTIONUS8283333
DESCRIPTIONUS8372951
DESCRIPTIONUS8404658
DESCRIPTIONUS8454972
DESCRIPTIONUS8575305
DESCRIPTIONUS8709843
DESCRIPTIONWO2011028929
DESCRIPTIONWO2012135025
DESCRIPTIONWO2013126794
DESCRIPTIONWO2013163628
DESCRIPTIONWO9116024
DESCRIPTIONWO9117424
DESCRIPTIONWO9324641
DESCRIPTIONWO9639154
DESCRIPTIONWO9703211
EXAMINATIONFR2872170
EXAMINATIONUS2006178297
INTERNATIONAL-SEARCH-REPORTWO2013082519
OPPOSITIONWO2013082519
OPPOSITIONWO2013176772

Non-Patent Literature (NPL) Citations (62) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- 121, "Virus-Mediated Genome Editing via Homology-Directed Repair in Mitotic and Postmitotic Cells in Mammalian Brain", Epilepsy Currents, American Epilepsy Society, (20180301), pages 121 - 122, Epilepsy Currents, URL: https://journals.sagepub.com/doi/pdf/10.5698/1535-7597.18.2.121, (20210329), XP055790868-
OPPOSITION- ALLEN et al., "Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database", Nature, (20080626), vol. 40, pages 827 - 834-
OPPOSITION- Et Al. Cong, "Addgene: pX330-U6-Chimeric _ BB-CBh-hSpCas9", Addgene's Blog, (20130103), pages 1 - 5, Addgene's Blog, (20170531), XP055377318-
OPPOSITION- GARRIGA-CANUT et al., PNAS, (20120000), vol. 109, no. 45, pages E3136 - E3145-
OPPOSITION- Genbank, Database accession no. CCK74173.1-
OPPOSITION- Genbank, Database accession no. H E980450.1-
OPPOSITION- Dabell Mindy Preston, Et Al, "Investigation of NRXN1 deletions: Clinical and molecular characterization", AMERICAN JOURNAL OF MEDICAL GENETICS PART A, Wiley-Liss, Inc., US, US, (20130401), vol. 161, no. 4, doi:10.1002/ajmg.a.35780, ISSN 1552-4825, pages 717 - 731, XP055790863
OPPOSITION- PAULK et al., "Adeno-Associated Virus Gene Repair Corrects a Mouse Model of Hereditary Tyrosinemia In Vivo", Hepatology, (20100400), vol. 51, no. 4, doi:10.1002/HEP.23481, pages 1200 - 1208, XP002648846
OPPOSITION- Joel Rousseau, Pierre Chapdelaine, Sebastien Boisvert, Luciana P. Almeida, Jacques Corbeil, Alexandre Montpetit, Jacques P. Tremblay, "Endonucleases: tools to correct the dystrophin gene", The Journal of Gene Medicine, John Wiley & Sons, (20111001), vol. 13, no. 10, doi:10.1002/jgm.1611, ISSN 1099498X, pages 522 - 537, XP055046742
OPPOSITION- Vittorio Sebastiano, Morgan L. Maeder, James F. Angstman, Bahareh Haddad, Cyd Khayter, Dana T. Yeo, Mathew J. Goodwin, John S. Hawkins, Cherie L. Ramirez, Luis F. Z. Batista, Steven E. Artandi, Marius Wernig, J.Keith Joung, "In Situ Genetic Correction of the Sickle Cell Anemia Mutation in Human Induced Pluripotent Stem Cells Using Engineered Zinc Finger Nucleases", Stem Cells, (20111101), vol. 29, no. 11, doi:10.1002/stem.718, ISSN 1066-5099, pages 1717 - 1726, XP055260055
OPPOSITION- Rubio Mary Anne T., Hopper Anita K., "Transfer RNA travels from the cytoplasm to organelles : tRNA travels from the cytoplasm to organelles", Wiley Interdisciplinary Reviews: RNA, John Wiley & Sons Ltd, United Kingdom, United Kingdom, (20111101), vol. 2, no. 6, doi:10.1002/wrna.93, ISSN 1757-7004, pages 802 - 817, XP055790859
OPPOSITION- Gilgenkrantz Hélène, Collin De L'hortet Alexandra, "Understanding Liver Regeneration", AMERICAN JOURNAL OF PATHOLOGY., Elsevier Inc., US, US, (20180601), vol. 188, no. 6, doi:10.1016/j.ajpath.2018.03.008, ISSN 0002-9440, pages 1316 - 1327, XP055790875
OPPOSITION- Frank Soldner; Jose Laganire; AlbertW. Cheng; Dirk Hockemeyer; Qing Gao; Raaji Alagappan; Vikram Khurana; LawrenceI. Golbe; RichardH. Myers; Susan Lindquist; Lei Zhang; Dmitry Guschin; LaurenK. Fong; B.Joseph Vu; Xiangdong Meng; FyodorD. Urnov; EdwardJ. Rebar; PhilipD. Gregory; H.Steve Zhang; Rudolf Jaenisch;, "Generation of Isogenic Pluripotent Stem Cells Differing Exclusively at Two Early Onset Parkinson Point Mutations", Cell, Elsevier, Amsterdam NL, Amsterdam NL, (20110610), vol. 146, no. 2, doi:10.1016/j.cell.2011.06.019, ISSN 0092-8674, pages 318 - 331, XP028382613
OPPOSITION- Qi Lei S.; Larson Matthew H.; Gilbert Luke A.; Doudna Jennifer A.; Weissman Jonathan S.; Arkin Adam P.; Lim Wendell A., "Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression", Cell, Elsevier, Amsterdam NL, Amsterdam NL, (20130228), vol. 152, no. 5, doi:10.1016/j.cell.2013.02.022, ISSN 0092-8674, pages 1173 - 1183, XP028987304
OPPOSITION- WANG et al., "One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering", Cell, (20130509), vol. 153, doi:10.1016/j.cell.2013.04.025, pages 910 - 918, XP028538358
OPPOSITION- Gilbert Luke A.; Larson Matthew H.; Morsut Leonardo; Liu Zairan; Brar Gloria A.; Torres Sandra E.; Stern-Ginossar Noam; Brandman Onn; Whitehead Evan H.; Doudna Jennifer A.; Lim Wendell A.; Weissman Jonathan S.; Qi Lei S., "CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes", Cell, Elsevier, Amsterdam NL, (20130718), vol. 154, no. 2, doi:10.1016/j.cell.2013.06.044, ISSN 0092-8674, pages 442 - 451, XP028680105
OPPOSITION- Nishiyama Jun; Mikuni Takayasu; Yasuda Ryohei, "Virus-Mediated Genome Editing via Homology-Directed Repair in Mitotic and Postmitotic Cells in Mammalian Brain", Neuron, Cell Press, US, US, (19000101), vol. 96, no. 4, doi:10.1016/j.neuron.2017.10.004, ISSN 0896-6273, page 755, XP085263996
OPPOSITION- SCHWANK et al., "Functional Repair of CFTR by CRISPR/Cas9 in Intestinal Stem Cell Organoids of Cystic Fibrosis Patients", Cell Stem Cell, (20131205), vol. 13, doi:10.1016/j.stem.2013.11.002, pages 653 - 658, XP055102691
OPPOSITION- Thomas Gaj, Charles A. Gersbach, Carlos F. Barbas, "ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering", Trends in Biotechnology, Elsevier Current Trends, (20130501), doi:10.1016/j.tibtech.2013.04.004, ISSN 01677799, XP055065263
OPPOSITION- Yamashita, M. ; Emerman, M., "Retroviral infection of non-dividing cells: Old and new perspectives", Virology, ELSEVIER, AMSTERDAM, NL, (20060105), vol. 344, no. 1, doi:10.1016/j.virol.2005.09.012, ISSN 0042-6822, pages 88 - 93, XP024896297
OPPOSITION- Wu, Z. Asokan, A. Samulski, R.J., "Adeno-associated Virus Serotypes: Vector Toolkit for Human Gene Therapy", Molecular Therapy, Elsevier Inc., US, US, (20060812), vol. 14, no. 3, doi:10.1016/j.ymthe.2006.05.009, ISSN 1525-0016, pages 316 - 327, XP005844824
OPPOSITION- Emmanuelle Charpentier, Doudna Jennifer A., "Biotechnology: Rewriting a genome", Nature, Macmillan Journals Ltd., etc., London, London, vol. 495, no. 7439, doi:10.1038/495050a, ISSN 0028-0836, pages 50 - 51, XP055338357
OPPOSITION- Philippe Horvath, Rodolphe Barrangou, "RNA-guided genome editing à la carte", Cell Research, (20130601), vol. 23, no. 6, doi:10.1038/cr.2013.39, ISSN 10010602, pages 733 - 734, XP055184973
OPPOSITION- Lovric Jasmina et al, "Terminal Differentiation of Cardiac and Skeletal Myocytes Induces Permissivity to AAV Transduction by Relieving Inhibition Imposed by DNA Damage Response Proteins", Molecular Therapy, No longer published by Elsevier, (20121101), vol. 20, no. 11, doi:10.1038/mt.2012.144, ISSN 1525-0016, pages 2087 - 2097, XP055790861
OPPOSITION- Dana Carroll, "A CRISPR Approach to Gene Targeting", Molecular Therapy, No longer published by Elsevier, (20120901), vol. 20, no. 9, doi:10.1038/mt.2012.171, ISSN 15250016, pages 1658 - 1660, XP055106489
OPPOSITION- David G Ousterout, Perez-Pinera Pablo, Thakore Pratiksha I, Kabadi Ami M, Brown Matthew T, Qin Xiaoxia, Fedrigo Olivier, Mouly Vincent, Tremblay Jacques P, Gersbach Charles A, "Reading Frame Correction by Targeted Genome Editing Restores Dystrophin Expression in Cells From Duchenne Muscular Dystrophy Patients", Molecular Therapy, No longer published by Elsevier, (20130901), vol. 21, no. 9, doi:10.1038/mt.2013.111, ISSN 15250016, pages 1718 - 1726, XP055184655
OPPOSITION- URNOV F D, ET AL., "Highly efficient endogenous human gene correction using designed zinc-finger nucleases", Nature, Macmillan Journals Ltd., etc., London, London, (20050602), vol. 435, doi:10.1038/nature03556, ISSN 0028-0836, pages 646 - 651, XP002467423
OPPOSITION- Marina Cavazzana-Calvo et al, "Transfusion independence and HMGA2 activation after gene therapy of human &bgr;-thalassaemia", Nature, Macmillan Journals Ltd., etc, London, London, (20100916), vol. 467, no. 7313, doi:10.1038/nature09328, ISSN 0028-0836, pages 318 - 322, XP055258765
OPPOSITION- Li H et al, "In vivo genome editing restores haemostasis in a mouse model of haemophilia", Nature, Macmillan Journals Ltd., etc, London, London, (20110714), vol. 475, no. 7355, doi:10.1038/nature10177, ISSN 0028-0836, pages 217 - 221, XP002688791
OPPOSITION- Li H, Haurigot V, Doyon Y, Li T, Wong S Y, Bhagwat A S, Malani N, Anguela X M, Sharma R, Ivanciu L, Murphy S L, Finn J D, Khazi F R, Zhou S, Paschon D E, Rebar E J, Bushman F D, Gregory P D, Holmes M C, High K A, "In vivo genome editing restores haemostasis in a mouse model of haemophilia", Nature, Macmillan Journals Ltd., etc., London, London, (20110714), vol. 475, no. 7355, doi:10.1038/nature10177, ISSN 0028-0836, pages 217 - 221, XP002688791
OPPOSITION- Kosuke Yusa, S. Tamir Rashid, Helene Strick-Marchand, Ignacio Varela, Pei-Qi Liu, David E. Paschon, Elena Miranda, Adriana Ordonez, Nicholas R. F. Hannan, Foad J. Rouhani, Sylvie Darche, Graeme Alexander, Stefan J. Marciniak, Noemi Fusaki, Mamoru Hasegawa, Michael C. Holmes, James P. Di Santo, David A. Lomas, Allan Bradley, Ludovic Vallier, "Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells", Nature, Macmillan Journals Ltd., etc., London, London, (20111012), vol. 478, no. 7369, doi:10.1038/nature10424, ISSN 0028-0836, pages 391 - 394, XP055265365
OPPOSITION- BARRANGOU, "RNA-mediated programmable DNA cleavage", Nature Biotechnology, (20120900), vol. 30, no. 9, doi:10.1038/nbt.2357, pages 836 - 838, XP055118675
OPPOSITION- HWANG et al., "Efficient genome editing in zebrafish using a CRISPR-Cas system", Nature Biotechnology, (20130129), vol. 31, no. 3, doi:10.1038/nbt.2501, pages 227 - 229, XP055086625
OPPOSITION- Seung Woo Cho, Sojung Kim, Jong Min Kim, Jin-Soo Kim, "Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease (includes Supplementary information)", Nature Biotechnology, Gale Group Inc., New York, New York, (20130301), vol. 31, no. 3, doi:10.1038/nbt.2507, ISSN 1087-0156, pages 230 - 232+1-11, XP002699850
OPPOSITION- YIN et al., "Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype", Nat Biotechnol., (20140330), vol. 32, no. 6, doi:10.1038/nbt.2884, pages 551 - 553, XP055176941
OPPOSITION- Prashant Mali, Kevin M Esvelt & George M Church, "Cas9 as a versatile tool for engineering biology.", NATURE METHODS, Nature Publishing Group, GB, GB, (20131001), vol. 10, no. 10, doi:10.1038/nmeth.2649, ISSN 1548-7105, pages 957 - 963, XP002718606
OPPOSITION- RAN et al., "Genome engineering using the CRISPR- Cas9 system", Nature Protocols, (20131024), vol. 8, no. 11, doi:10.1038/nprot.2013.143, pages 2281 - 2308, XP009174668
OPPOSITION- J. Keith Joung, Sander Jeffry D., "TALENs: a widely applicable technology for targeted genome editing", Nat Rev Mol Cell Biol., Nature Publishing Group UK, London, GB, vol. 14, no. 1, doi:10.1038/nrm3486, ISSN 1471-0072, pages 49 - 55, XP055282847
OPPOSITION- HEIDENREICH et al., "Applications of CRISPR- Cas systems in neuroscience", Nat. Rev. Neurosci., (20160109), vol. 17, no. 1, doi:10.1038/nrn.2015.2, pages 36 - 44, XP055300904
OPPOSITION- MITROPHANOUS K.A., ET AL., "STABLE GENE TRANSFER TO THE NERVOUS SYSTEM USING A NON-PRIMATE LENTIVIRAL VECTOR.", Gene Therapy, Nature Publishing Group, London, GB, (19990101), vol. 06., no. 11., doi:10.1038/sj.gt.3301023, ISSN 0969-7128, pages 1808 - 1818., XP000914884
OPPOSITION- GARRIGA-CANUT et al., "Synthetic zinc finger repressors reduce mutant huntingtin expression in the brain of R6/2 mice", PNAS, (20121010), vol. 109, no. 45, doi:10.1073/pnas.1206506109, pages E3136 - E3145, XP055161220
OPPOSITION- Fung Chan, William W. Hauswirth, Theodore G. Wensel, John H. Wilson, "Efficient mutagenesis of the rhodopsin gene in rod photoreceptor neurons in mice", Nucleic Acids Research, Oxford University Press, GB, GB, (20110801), vol. 39, no. 14, doi:10.1093/nar/gkr196, ISSN 0305-1048, pages 5955 - 5966, XP055699090
OPPOSITION- T. Cermak, E. L. Doyle, M. Christian, L. Wang, Y. Zhang, C. Schmidt, J. A. Baller, N. V. Somia, A. J. Bogdanove, D. F. Voytas, "Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting", Nucleic Acids Research, Oxford University Press, GB, (20110701), vol. 39, no. 12, doi:10.1093/nar/gkr218, ISSN 0305-1048, pages 1 - 11, XP055130093
OPPOSITION- M. Stadtfeld, K. Hochedlinger, "Induced pluripotency: history, mechanisms, and applications", Genes & Development, Cold Spring Harbor Laboratory Press, (20101015), vol. 24, no. 20, doi:10.1101/gad.1963910, ISSN 08909369, pages 2239 - 2263, XP055169674
OPPOSITION- Y. H. Sung, J. M. Kim, H.-T. Kim, J. Lee, J. Jeon, Y. Jin, J.-H. Choi, Y. H. Ban, S.-J. Ha, C.-H. Kim, H.-W. Lee, J.-S. Kim, "Highly efficient gene knockout in mice and zebrafish with RNA-guided endonucleases", Genome Research, Cold Spring Harbor Laboratory Press, US, US, (20140101), vol. 24, no. 1, doi:10.1101/gr.163394.113, ISSN 1088-9051, pages 125 - 131, XP055647267
OPPOSITION- Nikolaus R. Mcfarland, Jeng-Shin Lee, Bradley T. Hyman, Pamela J. Mclean, "Comparison of transduction efficiency of recombinant AAV serotypes 1, 2, 5, and 8 in the rat nigrostriatal system", Journal of Neurochemistry, Wiley-Blackwell Publishing Ltd., GB, (20090501), vol. 109, no. 3, doi:10.1111/j.1471-4159.2009.06010.x, ISSN 0022-3042, pages 838 - 845, XP055699094
OPPOSITION- JINEK et al., "A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity", Science, (20120817), vol. 337, doi:10.1126/science.1225829, pages 816 - 821, XP055549487
OPPOSITION- BROUNS, "A Swiss Army Knife of Immunity", Science, (20120817), vol. 337, doi:10.1126/science.1227253, pages 808 - 809, XP055113718
OPPOSITION- CONG et al., "Multiplex Genome Engineering Using CRISPR/Cas Systems", Science, (20130103), vol. 339, doi:10.1126/science.1231143, pages 819 - 823, XP055300065
OPPOSITION- Le Cong, F. Ann Ran, David Cox, Shuailiang Lin, Robert Barretto, Naomi Habib, Patrick D. Hsu, Xuebing Wu, Wenyan Jiang, Luciano A. Marraffini, Feng Zhang, "Multiplex Genome Engineering Using CRISPR/Cas Systems", Science, American Association for the Advancement of Science, US, US, (20130215), vol. 339, no. 6121, doi:10.1126/science.1231143, ISSN 0036-8075, pages 819 - 823, XP055458249
OPPOSITION- Prashant Mali1, Luhan Yang, Kevin M. Esvelt, John Aach, Marc Guell, James E. DiCarlo, Julie E. Norville, and George M. Church, "RNA-Guided Human Genome Engineering via Cas9 (plus Supplementary Materials)", Science, (20130215), vol. 339, no. 6121, doi:10.1126/science.1232033, pages 823 - 826,1-38pp, XP055613418
OPPOSITION- G Podsakoff, Wong K K, Chatterjee S, "Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors.", Journal of Virology, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, US, (19940901), vol. 68, no. 9, doi:10.1128/JVI.68.9.5656-5666.1994, ISSN 0022-538X, pages 5656 - 5666, XP055699091
OPPOSITION- Adiwinata Pawitan Jeanne, "Prospect of Induced Pluripotent Stem Cell Genetic Repair to Cure Genetic Diseases", Stem Cells International, Hindawi Publishing Corporation, US, (20120101), vol. 2012, doi:10.1155/2012/498197, ISSN 1687-966X, pages 1 - 7, XP055825689
OPPOSITION- DING et al., "Permanent Alteration of PCSK9 With In Vivo CRISPR-Cas9 Genome Editing", CirculationResearch, (20140610), vol. 115, doi:10.1161/CIRCRESAHA.115.304351, pages 488 - 492, XP055484541
OPPOSITION- Abolfazl Akbarzadeh, Rezaei-Sadabady Rogaie, Davaran Soodabeh, Joo Sang Woo, Zarghami Nosratollah, Hanifehpour Younes, Samiei Mohammad, Kouhi Mohammad, Nejati-Koshki Kazem, "N Liposome: classification, preparation, and applications", vol. 8, no. 102, doi:10.1186/1556-276X-8-102, (20130101), URL: http://www.nanoscalereslett.com/content/pdf/1556-276X-8-102.pdf, (20150324), XP055178982
OPPOSITION- Sivaprakash Ramalingam, Annaluru Narayana, Chandrasegaran Srinivasan, "A CRISPR way to engineer the human genome", Genome Biology, BioMed Central Ltd., (20130101), vol. 14, no. 2, doi:10.1186/gb-2013-14-2-107, ISSN 1465-6906, pages 1 - 4, XP055323697
OPPOSITION- STRAUB CHRISTOPH ET AL, "CRISPR/Cas9-Mediated Gene Knock-Down in Post-Mitotic Neurons.", PLoS ONE, Public Library of Science, US, US, (20140101), vol. 9, no. 8, doi:10.1371/journal.pone.0105584, ISSN 1932-6203, page e105584, XP002730475
OPPOSITION- SCHLACHETZKI et al., "Studying neurodegenerative diseases in culture models", Brazilian Journal of Psychiatry, (20130000), vol. 35, no. 2, doi:10.1590/1516-4446-2013-1159, pages S92 - S100, XP055279171
OPPOSITION- Papadakis E D; Nicklin S A; Baker A H; White S J, "Promoters and control elements: designing expression cassettes for gene therapy.", Current Gene Therapy, Bentham Science Publishers Ltd., NL, (20040301), vol. 4, no. 1, doi:10.2174/1566523044578077, ISSN 1566-5232, pages 89 - 113, XP009159935
OPPOSITION- Huai Jisen, Zhang Zhongjian, "Structural Properties and Interaction Partners of Familial ALS-Associated SOD1 Mutants", Frontiers in Neurology, vol. 10, doi:10.3389/fneur.2019.00527, XP055790872
OPPOSITION- Krzysztof Chylinski, Anais Le Rhun, Emmanuelle Charpentier, "The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems", RNA Biology, Landes Bioscience, (20130501), vol. 10, no. 5, doi:10.4161/rna.24321, ISSN 15476286, pages 726 - 737, XP055116068
OPPOSITION- Daoyan Wei Yongmin Yan, "The CRISPR-Cas9 System: A Powerful Tool for Genome Engineering and Regulation", Advancements in Genetic Engineering, vol. 02, no. 03, doi:10.4172/2169-0111.1000e103, page 1000e103, XP055699093

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents